share_log

Groupon Analyst Ratings

Benzinga ·  Aug 10, 2023 07:25
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/10/2023 -24.43% Barclays $4 → $6 Maintains Underweight
05/12/2023 -57.18% Credit Suisse $12 → $3.4 Maintains Neutral
03/20/2023 -49.62% Barclays $7 → $4 Maintains Underweight
03/20/2023 -43.32% Goldman Sachs $6.5 → $4.5 Maintains Sell
03/17/2023 51.13% Credit Suisse $15 → $12 Maintains Neutral
11/08/2022 -18.14% Goldman Sachs $10 → $6.5 Maintains Sell
11/08/2022 -24.43% Barclays $10 → $6 Maintains Underweight
11/08/2022 88.92% Credit Suisse $18 → $15 Maintains Neutral
08/10/2022 126.7% Credit Suisse $23 → $18 Maintains Neutral
08/10/2022 25.94% Barclays $12 → $10 Maintains Underweight
05/11/2022 52.39% Goldman Sachs $20 → $12.1 Maintains Sell
05/10/2022 51.13% Barclays $20 → $12 Maintains Underweight
05/10/2022 189.67% Credit Suisse $29 → $23 Maintains Neutral
03/24/2022 277.83% Ascendiant Capital $35 → $30 Maintains Buy
03/02/2022 265.24% Credit Suisse $38 → $29 Maintains Neutral
12/23/2021 340.81% Ascendiant Capital $40 → $35 Maintains Buy
12/15/2021 252.64% JP Morgan $38 → $28 Maintains Neutral
12/10/2021 189.67% Barclays $30 → $23 Maintains Underweight
08/09/2021 277.83% Barclays $35 → $30 Maintains Underweight
08/09/2021 378.59% Credit Suisse $42 → $38 Maintains Neutral
03/01/2021 504.53% JP Morgan → $48 Upgrades Underweight → Neutral
03/01/2021 340.81% Credit Suisse $31 → $35 Maintains Neutral
01/15/2021 328.21% Morgan Stanley $21 → $34 Maintains Equal-Weight
11/09/2020 290.43% Credit Suisse $30 → $31 Maintains Neutral
11/02/2020 164.48% Wedbush $27 → $21 Maintains Neutral
10/15/2020 164.48% Morgan Stanley $22 → $21 Maintains Equal-Weight
08/10/2020 277.83% Credit Suisse $32 → $30 Maintains Neutral
08/10/2020 303.02% UBS $30 → $32 Maintains Buy
06/19/2020 177.08% Morgan Stanley $18 → $22 Maintains Equal-Weight
05/07/2020 -88.66% Morgan Stanley $1.5 → $0.9 Maintains Equal-Weight
04/21/2020 -81.11% UBS $2.9 → $1.5 Maintains Buy
04/14/2020 -79.85% Credit Suisse $2 → $1.6 Maintains Neutral
02/21/2020 -81.11% Morgan Stanley $2.8 → $1.5 Maintains Equal-Weight
02/20/2020 -74.81% Credit Suisse $4 → $2 Maintains Neutral
02/20/2020 -63.48% UBS $3.5 → $2.9 Maintains Buy
02/20/2020 -77.96% Wedbush $3 → $1.75 Maintains Neutral
01/17/2020 -55.92% UBS → $3.5 Upgrades Neutral → Buy
12/23/2019 -59.07% Ascendiant Capital $4.25 → $3.25 Maintains Buy
12/17/2019 -69.77% Goldman Sachs → $2.4 Downgrades Neutral → Sell
11/06/2019 JP Morgan Downgrades Neutral → Underweight
02/04/2019 -55.92% Goldman Sachs → $3.5 Initiates Coverage On → Neutral
09/14/2018 -49.62% Wedbush → $4 Initiates Coverage On → Neutral

What is the target price for Groupon (GRPN)?

The latest price target for Groupon (NASDAQ: GRPN) was reported by Barclays on August 10, 2023. The analyst firm set a price target for $6.00 expecting GRPN to fall to within 12 months (a possible -24.43% downside). 8 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Groupon (GRPN)?

The latest analyst rating for Groupon (NASDAQ: GRPN) was provided by Barclays, and Groupon maintained their underweight rating.

When is the next analyst rating going to be posted or updated for Groupon (GRPN)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Groupon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Groupon was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.

Is the Analyst Rating Groupon (GRPN) correct?

While ratings are subjective and will change, the latest Groupon (GRPN) rating was a maintained with a price target of $4.00 to $6.00. The current price Groupon (GRPN) is trading at is $7.94, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment